SKLB-03220
SKLB-03220 is a selective and orally active EZH2 covalent inhibitor with an IC50 of 1.72 nM for EZH2MUT. SKLB-03220 exhibits weak activities against other tested histone methyltransferases (HMTs) and kinases. SKLB-03220 displays noteworthy potency against ovarian cancer cell lines and induces cell apoptosis. SKLB-03220 significantly inhibits tumor growth in PA-1 xenograft model. SKLB-03220 can be used for the study of ovarian cancer[1].
Product Specifications
CAS Number
[2852050-29-2]
UNSPSC
12352005
Target
Apoptosis; Histone Methyltransferase
Related Pathways
Apoptosis; Epigenetics
Field of Research
Cancer
Smiles
O=C(NC1=CC=C(C)C(C2=CC(N(C3CCOCC3)CC)=C(C)C(C(NCC4=C(C)C=C(C)NC4=O)=O)=C2)=C1)C=C
Molecular Formula
C33H40N4O4
Molecular Weight
556.70
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EZH2
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Porcine Mediator of RNA polymerase II transcription subunit 20 (MED20) ELISA Kit
Porcine Mediator of RNA polymerase II transcription subunit 20 (MED20) ELISA Kit
Porcine Mediator of RNA polymerase II transcription subunit 20 (MED20) ELISA Kit